Cryptocurrencies are moving out of the margins. They are settling into balance sheets. Bitcoin opened the dance, Ethereum followed.
Now, some altcoins are catching the attention of companies. The latest to take this step: Litecoin. The biotech company MEI Pharma has just made a big move. 100 million dollars injected into a treasury strategy exclusively based on this altcoin. An unprecedented event in the pharmaceutical sector.
